Verified Nov 2026
Batteries & E-Mobility
·

Lachen, Schwyz
·
Since 1983
Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.
Octapharma at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1983
Headquarters
Lachen, Schwyz
Import activity
8
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
8
Named foreign suppliers
3
Top origins
Mexico

Shared foreign counterparties do not establish that these companies buy from Octapharma.
What this tells a buyer
Octapharma recorded 8 customs shipments with origins in Mexico, supplied by affiliated entities including Octapharma De and Octapharma S A De C V.
The company produces medicines under GMP standards from human plasma and human cell lines, with R&D and manufacturing facilities across multiple countries including Switzerland, Austria, France, and the United States.
Octapharma serves healthcare systems, hospitals, and clinics across approximately 120 countries and operates over 180 plasma donation centers to source plasma for its therapeutic products.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
43 years in operation (founded 1983).
8 US import shipments on record.
Overview
Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.
At a glance
Attribute | Detail |
|---|---|
Founded | 1983 |
Headquarters | Lachen, Schwyz |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
What Octapharma makes
The company produces medicines under GMP standards from human plasma and human cell lines, with R&D and manufacturing facilities across multiple countries including Switzerland, Austria, France, and the United States.
Products and capabilities described on the company's own site include Transmission (source: octapharma.com).
Trade and customs footprint
Octapharma recorded 8 customs shipments with origins in Mexico, supplied by affiliated entities including Octapharma De and Octapharma S A De C V. US customs bill-of-lading records list 8 inbound shipments across 3 foreign suppliers, with top origins including Mexico.
Latest developments
2026-07-30 — Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC (octapharma.com)
2026-07-29 — Octapharma selects York County for its first US manufacturing site | S.C. Governor Henry McMaster (sc.gov)
2026-02-25 — Octapharma strengthens its innovation strategy with a USD 11.75 million Series A investment in Abram Scientific (octapharma.com)
2026-02-17 — Octapharma expands production for the global market at its manufacturing site in Vienna (octapharma.com)
2026-02-17 — Financial Review 2025 | Annual Report (octapharma.com)
2025-03-12 — Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) - Contracts Finder (service.gov.uk)
Facilities
Octapharma is headquartered in Lachen, Schwyz. Public sources also reference these locations:
Rock Hill, SC — octapharma.com
Austria, France — sc.gov
Vienna Vienna, Austria — octapharma.com
Lachen, Switzerland — linkedin.com
Company details
Octapharma serves healthcare systems, hospitals, and clinics across approximately 120 countries and operates over 180 plasma donation centers to source plasma for its therapeutic products. Octapharma was founded in 1983, has an estimated 10,000-50,000 employees, and is headquartered in Lachen, Schwyz. On the LightSource stability read it is rated "Established & active": 43 years in operation (founded 1983). 8 US import shipments on record.
Frequently asked questions
What does Octapharma make?
Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.
Where is Octapharma headquartered?
Octapharma is headquartered in Lachen, Schwyz (2 Seidenstrasse, Lachen, Schwyz, 8853).
When was Octapharma founded?
Octapharma was founded in 1983.
How big is Octapharma?
Octapharma has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
Does Octapharma import from overseas suppliers?
US customs bill-of-lading records show 8 inbound shipments for Octapharma, with top origins including Mexico.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
